Sprout Health Review

Sprout Health — Provider Profile

Overview

Sprout Health is a women-focused telehealth platform for weight management, founded in 2023 and based in Austin, TX. Unlike most GLP-1 telehealth providers that take a gender-neutral approach, Sprout specifically targets hormonal factors that affect weight loss in women — including PCOS, postpartum weight retention, perimenopause, and menopause-related weight gain.

April 2026 context: This provider is active and prescribing brand-name GLP-1 medications. Orforglipron (Eli Lilly oral GLP-1) is not yet FDA-approved — PDUFA date April 10, 2026. Medicare GLP-1 Bridge coverage for obesity is pending. Compounded semaglutide supply is declining under FDA enforcement pressure.

The platform pairs compounded GLP-1 prescriptions with a hormone panel at intake and ongoing registered dietitian support. The clinical premise is that hormonal imbalances (thyroid dysfunction, cortisol dysregulation, estrogen decline) can blunt GLP-1 medication response, and that addressing these factors alongside medication leads to better outcomes. This is a reasonable hypothesis grounded in endocrinology, though robust clinical evidence specifically linking hormone-guided GLP-1 dosing to improved weight loss outcomes remains limited.

Sprout is a small startup with limited brand recognition. It fills a genuine gap — most telehealth GLP-1 providers don't account for hormonal factors — but patients should weigh the platform's newness against its specialized approach.

Medications Offered

• Compounded semaglutide — GLP-1 receptor agonist, weekly subcutaneous injection
• Compounded tirzepatide — Dual GIP/GLP-1 receptor agonist, weekly subcutaneous injection

Sprout does not offer brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound). Patients who want or need brand-name options will need to look elsewhere.

Pricing

True monthly cost: $139/month for compounded semaglutide or $269/month for compounded tirzepatide. These are straightforward all-in prices — no membership fee layered on top. The semaglutide price is competitive with Ro ($149) and below Mochi Health's effective cost (~$178 after membership). Tirzepatide pricing is in line with the broader market.

The inclusion of a hormone panel and dietitian access at no extra charge adds meaningful value compared to competitors that charge separately for labs or nutritional support.

States Served

Available in 40 US states. The service is entirely virtual — no in-person visits. Sprout has not publicly disclosed which 10 states are excluded; patients should verify eligibility during signup.

Insurance

• Cash-pay only — Sprout does not accept insurance or handle prior authorizations
• HSA/FSA cards accepted
• No brand-name medications means no insurance pathway for medication costs
• No subscription commitment — cancel anytime with no penalties

Consultation Process

Model: Video consultations — not async-only.

1. Complete an online health intake covering medical history, weight goals, menstrual history, and hormonal symptoms
2. Hormone panel ordered at intake (estrogen, progesterone, testosterone, thyroid, cortisol)
3. Video consultation with a provider specializing in women's health and hormonal weight management
4. Treatment plan accounts for hormonal findings alongside standard GLP-1 prescribing criteria
5. Registered dietitian access included for ongoing nutritional guidance
6. Follow-up consultations via video as part of the program

The women's health specialization and hormone testing at intake distinguish Sprout from generic telehealth GLP-1 providers. Whether this translates to meaningfully better outcomes compared to standard GLP-1 prescribing is an open question — but at minimum, it provides a more complete clinical picture.

Pros

• Women-focused approach that accounts for hormonal factors (PCOS, menopause, postpartum, thyroid) affecting weight and GLP-1 response
• Hormone panel included at intake — estrogen, progesterone, testosterone, thyroid, cortisol
• Registered dietitian access included at no extra cost
• Competitive all-in pricing with no separate membership fee
• Video consultations with women's health specialists — not async questionnaires
• No subscription lock-in — cancel anytime

Cons

• Very new company (founded 2023) with limited track record and brand recognition
• Available in only 40 states — narrower coverage than major competitors
• No brand-name GLP-1 medications offered — compounded only
• Cash-pay only with no insurance option, even for brand medications
• Women-only platform — excludes men entirely
• Limited clinical evidence that hormone-guided GLP-1 dosing produces better weight loss outcomes than standard prescribing
• Small operation raises questions about long-term viability and pharmacy partner reliability

Best For

Women who suspect hormonal factors are complicating their weight management and want a provider that takes those factors seriously. Sprout is particularly relevant for women dealing with PCOS-related weight gain, postpartum weight retention, or menopause-related metabolic changes who feel underserved by gender-neutral telehealth platforms. The included hormone panel and dietitian access make it a more clinically thorough option than budget providers, at a price point that remains competitive.

Editorial Verdict

Sprout Health addresses a real gap in the GLP-1 telehealth market. Most providers treat weight management as a gender-neutral problem, ignoring the well-documented role of hormonal fluctuations in women's metabolism and weight loss response. Sprout's approach — hormone testing at intake, women's health specialists, and dietitian support — is clinically sound in principle, even if the specific evidence for hormone-guided GLP-1 dosing is still emerging.

At $139/month all-in for compounded semaglutide, the pricing is competitive and refreshingly transparent. The included hormone panel and dietitian access represent genuine added value that would cost extra (or simply not be available) at most competitors.

The concerns are real, though. This is a young startup with limited brand recognition and no public funding announcements — the kind of company that could pivot, scale back, or disappear. The 40-state footprint is narrower than established competitors. And the women-only model, while a strength for its target audience, means roughly half of potential patients need to look elsewhere.

For women who want more than a generic GLP-1 prescription and are comfortable with a newer platform, Sprout Health offers a meaningfully differentiated experience at a fair price. For patients who prioritize company stability or need brand-name medication options, established players like Hims, Ro, or Mochi Health are safer bets.

Related Content

• Best GLP-1 Weight Loss Programs 2026 — All providers ranked
• Cheapest GLP-1 Providers — Budget options compared
• GLP-1 Cost & Insurance FAQ — What you'll actually pay